Pinealon
Brain bioregulator peptide
Brain-targeted bioregulator.
Half-life
~ hours
Mol. weight
~ 417.4 g/mol
Sequence
Glu-Asp-Arg (EDR)
Discussions
0 threads
Overview
A short tripeptide bioregulator studied for regulating gene expression in brain tissue, with proposed support for neuronal function and neuroprotection. It applies the Khavinson bioregulator framework to the brain — conceptually analogous to the better-evidenced cognitive peptides (Semax, Selank) but via the ultra-short-peptide transcriptional approach.
Mechanism of action
Pinealon is a tripeptide bioregulator studied for regulating gene expression in brain tissue, with proposed support for neuronal function. It belongs to the Khavinson bioregulator class and is conceptually aimed at the same target organ (the brain) as the better-characterized cognitive peptides like Semax and Selank, but via the ultra-short-peptide transcriptional-regulation framework rather than defined receptor signaling. The brain is a challenging target for any peptide due to the blood-brain barrier.
Researched benefits
- Studied for brain/neuronal support
- Short, brain-targeted bioregulator format
- Conceptually aligned with cognitive-peptide research
Considerations
- Blood-brain barrier complicates brain-targeted peptides
- Evidence concentrated in one tradition
- Human data limited
Key Academic Literature & Studies
Search more in PubMedPeer-reviewed citations and clinical trials evaluating Pinealon in scientific literature.
Query PubMed for recent peer-reviewed preclinical and clinical publications on Pinealon:
View Pinealon index on PubMed (NCBI)